Bio-Works Technologies AB (BIOWKS) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.085x

Based on the latest financial reports, Bio-Works Technologies AB (BIOWKS) has a cash flow conversion efficiency ratio of -0.085x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-4.17 Million ≈ $-449.08K USD) by net assets (Skr49.21 Million ≈ $5.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see BIOWKS stock market capitalisation for the company's overall valuation and market capitalisation.

Bio-Works Technologies AB - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Bio-Works Technologies AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bio-Works Technologies AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bio-Works Technologies AB ranked by their cash flow conversion efficiency. Explore BIOWKS cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Sunnic Technology & Merchandise TWO:3360	-0.120x
Piolink Inc KQ:170790	0.042x
Inspirisys Solutions Limited NSE:INSPIRISYS	0.188x
TPC Consolidated Ltd AU:TPC	0.228x
Harrisons Malayalam Limited NSE:HARRMALAYA	0.033x
Global SM Tech Limited KQ:900070	0.009x
WM Technology Inc NASDAQ:MAPS	0.047x
Ittifak Holding A.S. IS:LRSHO	-0.028x

Annual Cash Flow Conversion Efficiency for Bio-Works Technologies AB (2015–2025)

The table below shows the annual cash flow conversion efficiency of Bio-Works Technologies AB from 2015 to 2025. View BIOWKS share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr49.21 Million ≈ $5.30 Million	Skr-18.81 Million ≈ $-2.02 Million	-0.382x	+60.52%
2024-12-31	Skr44.58 Million ≈ $4.80 Million	Skr-43.17 Million ≈ $-4.65 Million	-0.968x	+27.73%
2023-12-31	Skr44.03 Million ≈ $4.74 Million	Skr-58.99 Million ≈ $-6.35 Million	-1.340x	-127.40%
2022-12-31	Skr67.69 Million ≈ $7.28 Million	Skr-39.88 Million ≈ $-4.29 Million	-0.589x	-378.17%
2021-12-31	Skr108.51 Million ≈ $11.68 Million	Skr-13.37 Million ≈ $-1.44 Million	-0.123x	+89.36%
2020-12-31	Skr37.46 Million ≈ $4.03 Million	Skr-43.36 Million ≈ $-4.67 Million	-1.158x	-137.44%
2019-12-31	Skr82.13 Million ≈ $8.84 Million	Skr-40.04 Million ≈ $-4.31 Million	-0.488x	+13.37%
2018-12-31	Skr61.64 Million ≈ $6.63 Million	Skr-34.69 Million ≈ $-3.73 Million	-0.563x	-163.23%
2017-12-31	Skr99.32 Million ≈ $10.69 Million	Skr-21.23 Million ≈ $-2.28 Million	-0.214x	+65.04%
2016-12-31	Skr23.64 Million ≈ $2.54 Million	Skr-14.46 Million ≈ $-1.56 Million	-0.612x	-4.42%
2015-12-31	Skr22.41 Million ≈ $2.41 Million	Skr-13.12 Million ≈ $-1.41 Million	-0.586x	--

About Bio-Works Technologies AB

ST:BIOWKS Sweden Medical Instruments & Supplies

Market Cap

$35.62 Million

Skr331.04 Million SEK

Market Cap Rank

#23275 Global

#440 in Sweden

Share Price

Skr3.31

Change (1 day)

-0.90%

52-Week Range

Skr2.21 - Skr4.68

All Time High

Skr28.60